Table 1.
Variables | Value |
Age (years) | 58 (47–66) |
Sex | |
Female | 496 (48.6%) |
Male | 524 (51.4%) |
Functional status | |
Nonfunctional | 838 (82.2%) |
Functional | 164 (16.1%) |
Genetic syndrome | |
None | 895 (87.7%) |
MEN-1 | 85 (8.3%) |
VHL | 10 (1.0%) |
Symptomatic | |
N0 | 442 (43.3%) |
Yes | 558 (54.7%) |
Primary location | |
Head | 284 (27.8%) |
Uncinated | 44 (4.3%) |
Neck/body | 234 (22.9%) |
Tail | 401 (39.3%) |
Multiple | 51 (5.0%) |
Multiple tumor nodules | |
Single | 909 (89.1%) |
Multiple | 106 (10.4%) |
Tumor size (cm) 2.1 (1.4–3.5) | |
Lymph nodes metastasis | |
No | 623 (61.1%) |
Yes | 235 (23.0%) |
Ki-67 category | |
<3% | 412 (40.4%) |
3–20% | 249 (24.4%) |
>20% | 26 (2.5%) |
Tumor differentiation | |
Well | 781 (76.6%) |
Moderately | 89 (8.7%) |
Poorly | 20 (2.0%) |
Surgical technique | |
Open | 778 (76.3%) |
Laparoscopic/robotic | 239 (23.4%) |
Type of resection | |
Enucleation | 107 (10.5%) |
Classic PD | 129 (12.6%) |
Pylorus preserving PD | 159 (15.6%) |
Central pancreatectomy | 32 (3.1%) |
Distal pancreatectomy | 576 (56.5%) |
Total pancreatectomy | 17 (1.7%) |
Perineural invasion | 169 (16.6%) |
Major vascular resection | 49 (4.8%) |
Lymphadenectomy | 858 (84.1%) |
Number of lymph node retrieved | 10 (5–16) |
Operation time (min) | 235 (185–315) |
Blood loss (ml) | 200 (100–400) |
Margin status | |
R0 | 866 (84.9%) |
R1 | 154 (15.1%) |
Postoperative morbidity | 544 (53.3%) |
Severe complication (III–V) | 225 (22.1%) |
Adjuvant chemotherapy | 25 (2.5%) |